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Abstract: Objective: To analyse the extent to which political and social-economic inequality have affected malaria 
control programs for prevention and treatment from 1950 to 2011 in Uganda.  
Methods: My analysis is based on both ethnographic study findings over a one-year period with children who 
experienced war in northern Uganda in 2004-2005. The main objective of the research was to investigate children's 
illnesses and quests for therapy during a time of war. Additionally, I conducted a review of all policy documents and 
strategic plans by Uganda's Ministry of Health capturing experiences in implementing global and national health policies 
in malaria control.  
Findings: Wartime children rarely engage in preventive measures, use cheap and affordable antimalarials, most of which 
have been scientifically proven to be ineffective. In addition the earlier ‘war’ on the malaria mosquito and the more recent 
recommendation of Artemisinin-based Combination Therapy (e.g. Coartem) as the first-line drug for uncomplicated 
malaria have been largely unsuccessful ventures, because malaria control requires programmes focusing on the social 
determinants of disease, such as poverty, since these factors hinder people's ability to practice recommended measures. 
Programmes aimed at the zoonoses, parasites, or vectors and pharmaceutical/technological aspects of control and 
management of malaria, like indoor residual spraying, using insecticide treated nets, spraying with DDT and use of 
Artemisinin-based Combination Therapies for uncomplicated malaria are short-term approaches which do not contribute 
to eradication, as frequently announced and promoted. 
Conclusion: Socio-economic and political inequality are obstacles to effective malaria treatment and prevention 
programmes in Uganda and other resource-poor settings in sub-Saharan Africa.  
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HIGHLIGHTS 
• Socioeconomic and political inequalities are 
obstacles for malaria control. 
• Wartime children struggle to practice globally 
recommended malaria control measures.  
• Effective malaria control will address social-
determinants of disease. 
• Resource-poor settings require access to 
affordable and efficacious antimalarials. 
INTRODUCTION 
Malaria is endemic in 95% of Uganda and the 
remaining 5% are epidemic prone areas in the 
highlands of South West and East [1-4]. There are an 
estimated 70-100,000 deaths per year among children 
under five years of age due to malaria, and between 
ten and twelve million clinical cases are treated in the 
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established by the WHO for malaria control(i.e., for 
prevention and treatment) are difficult to implement by 
resource poor populations in settings like Uganda and 
yet these populations are the ones who bear the 
greatest brunt of malaria. The poor rarely engage in 
preventive and control measures, including case 
management with efficacious Artemisinin-based 
Combination Therapy (including Coartem), intermittent 
preventive treatment during pregnancy, vector control 
and epidemiology preventive preparedness responses 
[2, 3].The main obstacles are grounded in socio-
economic and political inequalities, as well as strained 
healthcare systems in resource poor settings, that 
make it difficult for global policies to be meaningful in 
these contexts. Furthermore, because a substantial 
proportion of Uganda’s population cannot easily afford 
Coartem, the country recently had to revisit its malaria 
policy, shifting in 2009 from exclusively recommending 
Coartem for first-line treatment to recommending 
Fansidar to high risk populations like pregnant women 
and children below five years of age [3]. 
As I analyse in this article, there is a stark divide 
between the recommendations of global health policies 
and the healthcare realities of local populations in 
socio-economically disadvantaged settings like rural 
A History of Malaria Control in Uganda Global Journal of Anthropology Research, 2015, Vol. 2, No. 1    39 
and war-affected areas in Uganda. When members of 
these populations are ill with malaria-related fever, 
commonly their treatment consists of accessible and 
affordable antimalarial medicines such as chloroquine 
and Fansidar (sulfadoxine/pyrimethamine), despite the 
fact that studies have proven that there are malaria-
resistant parasites that do not respond to these 
medicines [7]. For example, for the period 1999-2001, 
chloroquine treatment failures reached an average of 
33% in Uganda [8] and the treatment failures of 
Fansidar therapy increased from 5.5% to 12% during 
the period 1995-1998.  
In the next section, I will first present the 
methodology for the ethnographic research upon which 
this paper is based, followed by the findings regarding 
the history of malaria control in Uganda, covering a) 
prevention measures including prophylaxis, and b) 
treatment of malaria during the period from 1955-2011. 
In the same section, I also explore the disparities 
between national and/or global policy recommen- 
dations, on the one hand, and the treatment practices 
of resource poor persons, on the other. I aim to show 
how global health policies are reflected in past and 
present malaria control efforts in Uganda and how 
social and economic inequality influence malaria 
control efforts on the ground.  
The article followed grounded theory [9] in analysis 
of data and conclusion that addressing socio 
determinants of disease will contribute to malaria eradi- 
cation. Socio-economic differences imply differences in 
the extent to which the target population is able to 
engage in preventive measures for malaria and also 
purchase more efficacious but expensive antimalarials. 
Therefore, current globally accepted policies in malaria 
control may not be appropriate for resource poor 
contexts. 
METHODOLOGY 
In 2004-2005, a period when Coartem was 
frequently distributed to state-aided health centres 
through globally funded health programmes and Non-
Governmental Organizations (NGOs), I conducted an 
ethnographic study in northern Uganda among children 
to investigate their illness experiences and their quests 
for therapy. During the conflict in northern Uganda, 
children were among the estimated 2 million people 
displaced by armed conflict from their homes and 
livelihoods.  
Table 1: Socio-Demographic Characteristics of 
Ethnographic Sample (N=24) 
Characteristics  Boys(n=10) Girls(n=14) 
Age range(years) 10-15  10-15 
Average age(years) 13.8  13.4  
Education(years) 3-7  4-6 
Average Household size 4.9 4.5 
Child headed-households 5 4 
Caretakers of sick kin 1 3 
Parents in camps 4 7 
 
Children who participated in the ethnographic study 
met the criteria: were 8-16 years old, lived in child-
headed households, attended a primary school for 
displaced children. At the time of the study, there were 
six displaced primary schools in Gulu Municipality and 
the scripts are a collection from all the schools because 
I recruited those who are willing to extensively share 
their experiences- whereby the entry point would be 
answering questions in the interview guide, or 
diagrammatically representing their illnesses. Some 
children were the caregivers for an HIV/ AIDS patients 
who were either registered in the Presidents’ 
Emergency Plan for AIDS Relief (PEPFAR), at Lacor 
Hospital, or was a client of World Vision’s Antiretroviral 
Programme. The first encounter with these children 
was also-at -a-displaced primary school. 
Although it is difficult to conclusively say, how many 
children participated in all study methods, 24 children 
did participate in at least three techniques (see Table 
2). 
Table 2: Child Participants in Ethnographic Research 
Methods (N=415) 




Writing compositions/stories 150 150 
Interview with interview guide  165 315 
Drawing of Illness 100 415 
Focus group discussions  108 415 
Workshops  24 415 
In-depth interviews  24 415 
Participant observation 24 415 
Detailed narratives 24 415 
Ethnographic sample 24 415 
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When administering semi-structured interview 
guides I wrote down the answers on behalf of some 
children, though older children wrote down the answers 
themselves. Interviews were conducted throughout the 
year in this region with stable malaria transmission 
whether in rainy or dry season. Only data from in-depth 
interviews and focus group discussions were recorded 
using a digital recorder. I transcribed children's 
compositions/handwritten stories and data from indepth 
interviews within 24hours of fieldwork. Whereas some 
children wrote their stories in English, all interviews 
were conducted in Acholi, the local language in 
northern Uganda. Elsewhere [10, 11], I have discussed 
how intersubjectivity and shared biographical 
experiences influenced the research process, informant 
selection, data analysis and reporting to the extent that 
the outcome reflects the particular interactions between 
researcher and researched. Furthermore, the 
researcher was guided by the Convention on the 
Rights of the Child, Save the Children and UNICEF 
child rights-based perspective [12] which sees children 
not as passive recipients of support but as active 
individuals who play an important role in their own 
development, relationships and protection. 
Because some wartime children lived in child 
headed households, were caretakers of sick adult kin 
and/ or lived away from parents who resided in distant 
displaced camps, in their everyday lives they made 
independent decisions, including for their healthcare. 
They sometimes asked adults for guidance, or asked 
staff in the drug shops which medicines to buy for fever 
and malaria - but the child made the decision to go and 
buy medicine. That is what I call independent decision-
making in healthcare. Socio-economic factors like 
inability to raise sufficient resources limited their 
choices, and I will present narratives where children 
bought under-dose, cheaper drugs - even when they 
obtained prescriptions from health centers to buy 
efficacious Coartem, they bought chloroquine instead. 
Adults too were affected by economic hardships, which 
limited their choices, nevertheless, they made 
independent healthcare decisions. Many children 
engaged in income generating activities like fetching 
water for sale, taking care of neighbours’ children, 
small scale trade like salt, eggs, match boxes. Some 
Aid agencies provided food supplies, and MSF donated 
Coartem to state aided health centres, but they did not 
provide chloroquine because it had scientifically been 
proven ineffective. However, chloroquine was available 
in drug shops and pharmacies, and continues to be 
widely purchased. 
I observed clients in the regional referral hospital 
outpatient clinic and its pharmacy over a one month 
period, to find out what medicines were prescribed for 
clinically diagnosed malaria. The same observation 
exercise was conducted in 2010 for a duration of two 
months in six drug shops within Gulu municipality, to 
find out which medicines clients frequently requested 
for their malaria episodes and in what amounts they 
purchased them. 
During tri-monthly home visits with the 
24participants in the ethnographic study, they were 
asked which antimalarial medicines they had used – if 
any – in the past month. As shown in the text, 
ethnographic findings during war are consistent with 
the everyday experiences of many resource poor 
persons in post-conflict Uganda regarding the extent to 
which they can practice globally recommended ideas 
about malaria prevention and control. In Gulu district, 
like all holoendemic rural districts in Uganda, the 
situation is more precarious in health centres since 
they no longer receive any donations of Coartem from 
emergency aid agencies. 
For this article, secondary data covering Uganda’s 
history of malaria control, as well as current strategies 
and challenges, were collected through a systematic 
review of 20 malaria control strategic plans, the demo- 
graphic survey reports and health policy documents 
from the Ministry of Health between 1995 and 2011.  
ETHICAL CONSIDERATIONS 
This study was approved by the Uganda National 
Council for Science and Technology. In addition, 
permission was sought and granted from the Gulu 
District Health and Education Offices. Prior to 
interviewing school children, permission was sought 
from school teachers and their adult caretakers. For the 
observations in health centres and outpatients units, 
permission was obtained from the regional referral 
hospital administrator and drug shop owners to 
observe and verify the type and quality of antimalarial 
medicines they distributed to clients. All respondents 
who participated in this study were assured of 
confidentiality and anonymity. Names used in this study 
are therefore pseudonyms to protect the participants’ 
identities. 
MALARIA CONTROL IN UGANDA: HISTORICAL 
AND ETHNOGRAPHIC PERSPECTIVES 
Information in this section is presented and 
analysed in two main parts covering prevention and 
treatment of malaria. The first part shows how 
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historical-political approaches in malaria control are 
significantly affected by the variations in socio-
economic and political commitment and type of state 
leadership in Uganda. For instance, although there is 
some evidence that in the 1950s Uganda was making 
attempts to engage with the global agenda in malaria 
control [13, 14], during the dictatorial regime of the late 
Idi Amin in the early 1970s, there was a limited focus 
on and implementation of disease control programmes. 
During this latter period Uganda experienced major 
economic hardship, whereby its population was unable 
to access even basic daily needs, let alone practice 
recommended preventive measures. However, with 
increased political commitment since the mid-1980s 
[15], the state has embraced the global disease control 
agendas, including the Roll Back Malaria (RBM) 
programme. Nevertheless, contextual factors such as 
poverty, as well as the effects of war, including 
displacement of people from their homes and 
livelihoods in northern Uganda affects the extent to 
which malaria prevention programmes can be 
implemented [16].  
In the subsequent part, ethnographic and secondary 
data obtained through review of malaria control 
strategic plans in Uganda [2, 3, 5] are presented 
concurrently. The main finding during the ethnographic 
study was that respondents rarely engaged in 
preventive measures, including the use of insecticide 
treated mosquito nets (ITNs) and weekly prophylaxis. 
In addition, they frequently used affordable chloroquine 
and Fansidar – antimalarials that have been proven to 
be ineffective due to the presence of malaria resistant 
strains of Plasmodium falciparum (one of the species of 
Plasmodium, the protozoan parasite that causes 
malaria in humans). 
Furthermore, a chronological review of all policy 
documents about malaria control was conducted, 
starting with how the focus on the malaria vector – the 
female Anopheles mosquito – was adapted and 
implemented in Uganda in an attempt to eradicate 
malaria [13]. The discussion section problematises the 
global health agenda recommendations for proposed 
preventive measures, including use of insecticide 
treated nets, indoor residual spraying, and the use of 
efficacious Coartem as a first-line drug, among 
resource poor populations and health centres that in 
Uganda have been consistently poorly stocked with 
drugs and managed with minimal state budgets [16]. 
Furthermore, contextual national factors include the 
Ugandan government's infrequent distribution of nets to 
resource-poor persons– an activity heavily dependent 
on donor funding. When nets are distributed, they are 
often of poor quality and the beneficiaries rarely use 
them properly. In addition, weak referral systems, 
insufficient information about new drugs, inadequate 
manpower at district, health facility and community 
level to handle case loads, especially in epidemic 
situations, affect malaria control efforts [18].The main 
argument rests on the fact that even though being part 
of the global health agenda is important for Uganda, in 
terms of learning about the efficacy of antimalarials and 
how to effectively control malaria, social-economic and 
political factors and inequality present significant 
obstacles to achieving these goals. 
Other factors include socio-cultural factors – e.g. as 
has shown for malaria control in neighbouring 
Tanzania, people prefer to use herbal medicine which 
is made from the non-synthetic, locally grown medicinal 
plant Artemisia annua. Further, [21], discuss 
"processes of localisation" implying that patients may 
have their own treatment priorities even in those states 
where they have access to broadly recommended 
therapies and/or preventive measures. In the following, 
however, I focus mainly on the socio-economic and 
political barriers to the successful implementation of 
malaria control programs in Uganda – while 
acknowledging at the same time that children living in 
conflict situations have their own, culturally shaped 
ideas regarding treatment of illness episodes, including 
the recurring self-medication with traditional medicine.  
HISTORY OF MALARIA PREVENTION MEASURES 
IN UGANDA (1950-1998) 
From the 1950s until the early 1990s, Uganda’s 
efforts to control malaria with respect to prevention 
were narrowed to environmental management in some 
municipalities and towns; rural areas were left out[14]. 
The main focus was on the mosquito as the transmitter 
of the disease, and in line with the 1948 WHO strategy, 
malaria eradication efforts were linked to eradication of 
vectors. Within this approach, target municipalities 
constructed drainage channels (also called malaria 
channels) with the aim of reducing breeding sites for all 
mosquitoes. Water was drained out as a way to 
engage in the ‘war on the mosquito’ [13, 14].  
During this same period, the WHO pioneered a 
malaria eradication programme through mass spraying 
with Dichloro-Diphenyl-Trichlororethane (DDT), synthe- 
sised by a Swiss company in the 1930s. When applied 
to the wall of a house, DDT can kill mosquitoes for 
months. Sprayed into a pond, mosquito larvae will die, 
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as will any adult mosquitoes [22, 23]. Indoor residual 
spraying of DDT was implemented on a large scale 
only as part of the WHO pilot programme between 
1959 and 1963 in the southwest Kigezi and Masaka. 
While significant reductions in malaria transmission 
were achieved [14, 22], indoor residual spraying was 
never implemented or scaled up as a national 
programme because of lack of resources and the 
coincidence with the end of the global malaria 
eradication campaign through the ‘war on the mosquito 
in the year 1970’ [23]. 
The focus on vectors was also largely critiqued by 
social scientists, who proposed that effective control 
measures for malaria needed to focus on the social 
determinants of the spread of disease [24-26]. Malaria 
is the outcome of a complex relational exchange; it is 
textured by unpredictable proximities that disappear 
when malaria is scaled up to a global matter. 
Furthermore, adapted global health agendas in malaria 
control have had unintended consequences for 
Uganda’s Ministry of Health(MOH); for instance, the 
immediate problem of eradication programmes is that 
they create false expectations, but additionally they 
lead governments to abandon more mundane, budget 
draining, but ultimately effective control policies [27].  
In short, while malaria is an infectious disease, with 
known vectors and with known ways to eradicate them, 
malaria is also a socio-economic issue. People most 
affected by this easily preventable and treatable 
disease are the poor who occupy the lowest echelon of 
the socioeconomic spectrum. These people find it 
difficult to practice preventive measures such as 
weekly prophylaxis or spraying their residences with 
DDT. In addition, use of DDT has become contentious 
in the recent past, since environmentalists have argued 
that its constant use causes dangerous health 
problems such as cancer. A significant policy landmark 
in malaria control in Uganda occurred in 1995 when the 
Ministry of Health created a Malaria Control 
Programme [2, 3] to direct and guide prevention and 
treatment activities. The MOH/MCP monitored 
resistance levels in the parasite and prepared for 
treatment policy changes [2-5]. For instance, the 
MOH/MCP once again recommended indoor residual 
spraying with DDT, a practice which had been used 
only sporadically during epidemics, including when 
Uganda experienced floods in the eastern and central 
regions. This initiative was, however, only implemented 
on a small scale, guided by local initiatives mainly in 
the southwest, as well as in selected institutions 
including boarding schools and barracks. With 
mosquito nets used in very few areas of Uganda, 
mainly around Lake Kyoga, the introduction of ITNs 
started with small trials and projects in the early 1990s. 
First, district-based distribution/sales were carried out 
through non-governmental organisations (NGOs) and 
bilateral organisations (e.g., African Medical and 
Research Foundation [AMREF] and German Technical 
Cooperation [Deutsche Gesellschaftfür Technische 
Zusammenarbeit – GTZ]), but these did not exceed 
several thousand nets per year.  
CURRENT MALARIA PREVENTION EFFORTS 
(1998-2005) 
As I will show below, there has been a gradual shift 
in approaches in malaria prevention to involving multi-
pronged methods, because of failed past experiences. 
Although there is still advocacy for preventive 
measures, more complex forms are suggested, to 
include prophylaxis, indoor residual spraying, and use 
of ITNs. This era included the launch of Roll Back 
Malaria in 2007. The Roll Back Malaria Global Malaria 
Action Plan has five succinct but ambitious targets; 
indeed, the action plan revived mid-20
th
 century 
dreams of living in a ‘malaria free world’ [28]:  
Until 2010 universal coverage of interventions such 
as bed nets and malaria case management is to be 
achieved. Malaria cases are to be reduced by 50 per 
cent in 2010 and by 75 per cent in 2015; deaths are 
supposed to sink near zero by 2015. In 8-10 countries 
malaria is to be eliminated by 2015; and finally in the 
long-term the aim is to eradicate malaria worldwide.  
With its main financing coming from philanthropic 
institutions, including the Bill and Melinda Gates 
Foundation (BMGF), the campaign takes Sub-Saharan 
Africa as its primary battleground. The approach of the 
BMGF has been criticised widely for its reliance on 
‘quick fix’ solutions [27]; nevertheless, the speculative 
logic attendant to bioeconomy is integral to the revival 
of malaria eradication. 
Since the early 2000s, the Malaria Control 
Programme has been based on the principles and aims 
of the global Roll Back Malaria movement, the Abuja 
Declaration by African Heads of State, and the 
Millennium Development Goals. The Ugandan Ministry 
of Health and its Malaria Control Programme works 
within this framework with line ministries, civil society, 
Non-governmental organisations, development partne- 
rs and the private sector in order to achieve the set 
objectives and targets [30]. 
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Some of the targets include to ensure universal 
access to Coartem and improved diagnosis, as well as 
severe malaria management; emphasis on treatment 
and prevention of malaria in pregnancy, integration of 
malaria control into a balanced health system 
development with emphasis on human resource 
development and strong management, evaluation and 
operational research to monitor progress, evaluate 
impact and continuously improve interventions [31, 32].  
In line with the malaria control principles at that 
time, in the financial year 2000/2001 Uganda was one 
of the first countries to introduce a waiver of taxes and 
tariffs for ITNs. This helped in the rapid development of 
a commercial mosquito net and ITN sector, which has 
since shown exponential growth rates [33]. Prior to 
these initiatives in malaria control, the main approach 
was to treat clinical cases with chloroquine. In the 
recent past, [33] suggested that substantial results 
have been realised towards effective malaria control. 
For instance, knowledge of malaria, including its 
severity and the major risk groups, has steadily 
increased in the population and now generally reaches 
levels over 80%; the demand for preventive measures 
such as ITNs has also rapidly increased, along with the 
establishment of a viable commercial market for these 
products and distribution mechanisms through civil 
society and the public sector. This has resulted in an 
increase of the proportion of households with at least 
one mosquito net, from 13.2% to 25.9% [33]. Notably, 
the increase in mosquito net coverage in households 
was only made possible by philanthropic funds in 
malaria control. The sustainability of this approach is 
thus questionable since the beneficiaries largely 
depend on financing from Global Fund to Fight AIDS, 
Tuberculosis and Malaria (GFATM) and BMGF, without 
whose assistance they cannot engage in these 
preventive measures. Furthermore, a follow-up 
assessment found misuse of the mosquito nets, e.g. as 
curtains, as well as non-use as recipients in northern 
Uganda argued that it made sleep uncomfortable in 
their already hot surroundings [34]. Marketing of 
mosquito nets has also met with difficulties including 
general poverty and failure by the rural population to 
prioritise this malaria-prevention technology as a way 
of minimising infections by plasmodium falciparum. In 
addition, using or not using bed nets is often ignored 
when most people assert that they get bitten before 
going to bed (at dusk, when people are mostly outside 
preparing or eating food).  
I will now show how malaria treatment in Uganda is 
also affected by global health recommendations on one 
hand and the accessibility and affordability of 
antimalarials – as well as practices and priorities of 
individuals – on the ground, on the other.  
TREATMENT VARIATIONS AND POLICY 
RECOMMENDATIONS (1986-DATE) 
With the rapid recovery of the Ugandan economy 
after 1986, accompanied by state support for global 
health policies, access to medicines improved 
dramatically, not only through government and NGO-
based health facilities but also and particularly through 
the private for-profit sector. In many areas, drugs 
obtained from drug-shops or private clinics became the 
principle source for malaria treatment, reaching 
between 60% and 83%, of all malaria drugs purchased 
depending on the trading infrastructure of the area [35]. 
The mid-1980s also coincided with global Structural 
Adjustment Programmes and liberalisation of the 
market economy, culminating in the easy availability of 
pharmaceuticals as commodities [15]. One of the 
unintended consequences of easy pharmaceutical 
access is over-use and abuse of medicines, leading to 
drug resistance to antimalarial drugs like chloroquine 
[36].  
In effect, Uganda has benefitted significantly from 
embracing the global health agenda, including being 
able to access current information about the efficacy of 
malarial medicines such as Coartemand, knowledge 
about prevention, including the importance of ITNs, 
treatment, and drug resistance, such as Plasmodium 
falciparum’s resistance to chloroquine and the female 
Anopheles mosquito’s resistance to DDT. For instance, 
[37] has suggested that in the age group one to fifty-
nine months, about six lives in every thousand could be 
saved every year if regular and proper use of ITNs is 
guaranteed. Nevertheless, the effectiveness of ITNs is 
called into question in real life conditions, where social, 
cultural, and economic factors influence routine use 
and regular treatment.  
However, after the store of donated Coartem was 
depleted, it emerged that a substantial proportion of 
people affected by malaria [36] could not afford the 
recommended first-line drug. In 2005, the officer in 
charge of the Malaria Control Programme was moved 
to a less prestigious Neglected Disease section for 
opposing the recommendation that Coartem be the first 
line drug because the general population would be 
unable to afford it.In addition, household studies on the 
average expenditure on malaria treatment (direct cost) 
in the mid-1990’s found that it varied between US$ 
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4.10 in urban and $ 1.80 in rural settings [5]. These 
costs are likely to have increased in view of increased 
parasite resistance to a number of anti-malarial drugs 
in the recent past. Concrete data is lacking, but with 
recommendation of Coartem as first line medicine for 
malaria, whose average cost is 10 times more than for 
chloroquine and Fansidar [36], an average estimate 
could vary between US $ 40.1 in urban and US $18.0 
in rural areas if people were to manage their malaria as 
per the recommendations. The costs will be incurred by 
the clients since the state-aided health centres rarely 
have required medicines.  
CHILDREN’S EXPERIENCE OF MALARIA 
TREATMENT DURING WARTIME 
In this section, I present ethnographic research 
findings about the experiences of children obtaining 
malaria treatment during a period of war, as evidence 
that people living in war situations and in rural areas 
frequently resort to cheaper malaria medicines. The 
findings below suggest that chloroquine and Fansidar 
are the main pharmaceuticals used by many people 
living in poverty in rural Uganda who have limited 
access to health facilities, which tend to be located in 
urban areas.I therefore critique an underlying assump- 
tion that the people at risk ofmalaria will help to offset 
some of the running costs for policies in malaria control 
if they buy the expensive drugs [28].  
During the ethnographic study in wartime northern 
Uganda, over four hundred school children wrote 
about, represented diagrammatically, or narrated their 
experiences with malaria within a one month recall 
period. Some of the recorded narratives are presented 
in the Table 3 below. 
Furthermore, I present here the narratives of 
‘Okello, Acan and Achiro to show symptoms leading to 
self-diagnosis, experiential severity, and the differential 
Table 3: A selection of Narratives Depicting Prevention and Treatment of Malaria 
Preventive Measures for Malaria Treatment Options for Malaria  
We do not have mosquito nets at home. We only close 
windows early to reduce the number of mosquitoes 
entering the hut, but still when I go to bed I find the 
mosquitoes all over (14 year old boy, Interview in 
September 2005). 
When I went to hospital, the doctor told me I had malaria. He wrote that i should 
buy Coartem to treat it. At the hop they wanted a lot of money, and I did not have it. 
The shop owner told me to buy chloroquine. I bought 4 tablets of choroquine at 100 
shillings (15 year old girl, Interview in November 2005). 
My mother is registered in a project for people with 
HIV/AIDS in World Vision. One day they gave her a 
mosquito net. She has been using it for a long time. 
Presently its torn, so all of us sleep on a mat without 
using a mosquito net( 16 year old boy. FGD, 
November 2015). 
Last month i had malaria. When I told our neighbour that I was feeling fever, 
headache and that I vomited everything I ate, she gave me some two tablets of 
chloroquine and one fansidar. She told me to swallow them with warm water. After 
two days I began feeling better (13 year old girl, Interview in December 2005).  
When MSF distributed mosquito nets to orphans in the 
camp, we were given one. But my brother sold it, so 
that we can get money for food(16 year old girl, 
interview in November 2015). 
The last time I had malaria, my grandmother bought for me 4 tablets of chloroquine 
and 2 fansidar. After taking the medicines, I vomited. My uncle later in the same 
evening bought for me 2 Panadol and 4 chloroquine. I took all the medicines. The 
next day I was not ok. I went to school but the teacher told me to go to hospital. At 
the hospital I was given one injection, and the nurse said it was quinine. She told 
me to go back the next day. I went back with my grandmother. I became ok after 
one week. (15 year old boy, Interview in December 2005). 
Although we were taught at school about how to 
prevent malaria, no one is doing anything about it. My 
mother told me she has no money for buying a 
mosquito net( 12 year old girl, FGD in November 
2005). 
As I write this composition, I have left my sister at home because she has malaria. 
Our neighbour gave her some bitter and white medicines, which she called 
chloroquine. She is improving, but is still too weak to go to school(15 year old boy, 
essay in November 2005). 
We have a mosquito net, but we have not used it yet. 
MSF people told us to tie it at the roof of the hut and 
then spread it around the mat. But when we do that, it 
does not reach the floor (14 year old boy, interview 
and home visit in October 2005). 
When my mother has malaria, she sends me to the World Vision clinic to bring for 
her some medicines. But sometimes, I find when they have none. So we can buy 
some chloroquine from the drug shop, or we can ask the man who has a shop to 
give us some medicine for malaria, then we pay him later (14 year old girl, 
Interview in November 2005). 
At the World Vision, we were given a mosquito net. 
Only my uncle uses it since he is sickly and weak. 
Neighbours say he has HIV/AIDS(13 year old girl, 
interview in December 2005). 
That week when my mother received a mosquito net from World Vision, the 
headmaster had sent me home for examination fees. Because my mother did not 
have money, she sold the net to our neighbour who has a shop in town. So she 
does not use a mosquito net, even when she tells the counsellor that she does so. 
But when she has malaria, she goes to the clinic and they give her medicines (15 
year old girl, interview in December 2005).  
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quality and quantity of the medicines that children 
accessed malaria. 
Fourteen year old Okello wrote the composition as 
follows 
• As I write this story, I still have medicine at home 
for malaria. Just on Friday when I left school, I 
was feeling some headache and did not feel like 
eating anything. When my friends came for me 
to go and play, I told them I was not feeling well. 
At that time now, I was feeling very cold and my 
body was shaking. I asked a neighbour for some 
medicine for koyo and he gave some 
chloroquine and Panadol. By the time it was 
night, I was still feeling cold, and headache, so I 
told my brother to use some of the money I had 
got from selling sugarcane to go and buy 
Fansidar. In the shop, they also told him to buy 
more chloroquuine and Panadol. I swallowed two 
Fansidar and 2 Panadol. By morning I was 
feeling better, but my brother told me to continue 
taking medicine until they I finish them. 
Furthermore, 13 year old Acan narrated her story in 
this way 
• That Saturday when we were supposed to come 
for the workshop, I woke up feeling very weak. 
After brushing my teeth, I wanted to eat some 
food, but my mouth tasted bitter. After a few 
minutes I vomited. I was feeling headache and 
my body was hot. I asked Otim to go and ask his 
mother if he has some medicine for malaria. He 
came back with some chloroquine. The mother 
told him that I should drink it with warm water so 
that I do not vomit again. I took, three 
chloroquine that morning and the next day two 
tablets. That is how I became ok.  
Furthermore, 14 year old Achiro narrated the 
following: 
• When the term ended, I went to the camp in 
Pabbo to be with my parents. Just that week I 
felt sick. It started with headache and I was 
feeling weak. I vomited everything my mother 
gave me to eat or drink. She my mother touched 
my chest, she said I had lyeto (fever). She went 
and bought chloroquine and Panadol. I first took 
3 tablets of chloroquine and two of Panadol. The 
next day she gave me two chloroquine and one 
Panadol, but I was not feeling ok. She went and 
bought 3 Fansidar which she gave me in the 
evening. Before I went to slept, she also gave 
me some herbal medicine (yatAcholi) for 
headache and chest pain. The next day I woke 
up feeling a bit better.  
One key finding in the foregoing narratives is that 
children self-medicated or only bought medicines for 
malaria episodes with sub-clinical doses without prior 
consultation with any professional healthcare giver. 
This is in line with evidence that self-medication is 
usually the first choice for most people in rural and 
urban parts all over the world [38, 40]. 
Furthermore, whereas at the time of this study there 
were major policy revisions underway in malaria control 
– in the form of a shift from the previous 
recommendation that children of school age take 
chloroquine to recommending Coartem as a first-line 
drug – the children in the study indicated buying 
chloroquine and Fansidar for their malaria-related 
fever. Despite the recommended treatment regime – 
which states that school age children should take four 
tablets of chloroquine on the first day of diagnosis, and 
subsequently two tablets on the second and third day 
of treatment (i.e., a regimen of 4:2:2,) – findings 
suggest that children only took medicines at below the 
recommended doses. The foregoing is common in 
malaria treatment where dosages are stopped as soon 
as symptoms disappearor poorly stored and expired 
drugs are taken from former malaria episodes. Some 
easily accessed drugs are fake antimalarials [39]. 
Another issue from the narrative is sharing of medicine, 
which could have been poorly stored or stored beyond 
the expiry date. Children also took under-dosages for 
their malaria episodes and claimed to have recovered.  
Chloroquine causes itching in some people, but this 
could be avoided by taking Piriton or other 
antihistamines -no child discussed having done so. 
Neither were such additional tablets given to people 
who exhibited allergic reactions to the free antimalarials 
provided in state aided hospitals. An alternative would 
be to take other types of antimalarials such as 
Fansidar, quinine, Artenam, and Coartem, but these 
are often more expensive than chloroquine, and 
therefore few children could afford them [16].  
Even at the time of writing this paper, many people 
living in northern Uganda were seen asking 
forchloroquine and/or Fansidar for malaria-related 
symptoms like fever, vomiting, and headache in clinics 
and drugshops. These drugs are always given in 
quantities that they can afford. In a one day 
observation exercise in June 2010 in a drug shop 
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located near Gulu Regional Referral Hospital, eight of 
eleven patients, after consulting in the outpatient unit 
and being told there was no Coartem in the hospital’s 
pharmacy, bought chloroquine, Fansidar, and 
paracetamol syrups instead, which were more 
affordable. One mother discussed her drug choice as 
follows, following enquiry as to why she preferred to 
buy chloroquine and not the prescribed Coartem: 
• Chloroquine also works well for malaria. For me I 
have ever used Coartem only once when I was 
given for free in the hospital. On another 
occasion when I asked for it in this drug shop, I 
found the price was too high. From that day, I 
only ask for either chloroquine or Fansidar if I 
have malaria. 
During the researcher's fieldwork, many children 
also wrote about their experiences with malaria which 
they treated with Chrolorquine and Panadol. For 
example, 14-year old Okello wrote:  
• I had malaria last week because of any 
mosquitoes in the night commuters’ shelter. I 
knew it was malaria because I had headache, 
dizziness, coldness and I wanted to be under the 
sun all the time. I went to the drug store near 
home and I bought Chroloquine and Panadol for 
one hundred Shillings each. 
Furthermore, one 14 year old boy wrote about the 
lack of medicines in the hospitals as follows: 
• When I had malaria, I bought Panadol and 
Fansidar from a shop near home. I first went to 
the hospital alone but I found that the medicines 
were finished. I went to another hospital but they 
were asking for a lot of money. Idid not have a 
lot of money. 
CURRENT MALARIA CONTROL CHALLENGES  
At the national level, Uganda’s malaria control 
programme is faced with two main challenges, 
including the vulnerability of war-affected persons and 
the general poverty of its rural populations. Malaria 
poses an additional burden for war-affected 
populations, especially in north and south-western 
Uganda, because of the poor living conditions in 
displaced persons’ camps. In 2004, a household 
survey in northern Uganda reported up to five times 
more malaria-related deaths among war-affected 
people [41]. 
It should be noted that Uganda’s malaria control 
programme improved significantly between 2000 and 
2005 with a grant from the GFATM. The main 
contributor to this fund is the Bill and Melinda Gates 
Foundation. For example, a fund of fifty-five million 
USD was invested in malaria control in 2001, and a 
higher amount of seventy-three million dollars was 
invested in this activity in 2005. The UDHS [33] 
reported that control of malaria was at its highest 
during this period, which also coincides with an 
adoption of a policy recommending a relatively 
expensive regimen of Coartem as the first-line drug for 
uncomplicated malaria.  
The funds from philanthropists were mostly meant 
for improving technological aspects in malaria control, 
and there was limited focus on the social and economic 
determinants of the disease. The Global Fund money 
was meant primarily for indoor residual spraying, 
distribution of free ITNs, and the provision of 
microscopes for quality laboratory diagnosis of malaria. 
In addition, in 2004, due to the availability of these 
funds, in order to enable broad access to Artemisinin-
based Combination Therapy also in the private for-
profit sector, artesunate-amodiaquine(trade name 
Coarsucam)was defined as an alternative first-line 
treatment [42]. 
Nevertheless, the major challenge is how to make 
Artemisinin-based Combination Therapy available not 
only through the public sector but also through the 
many for-profit outlets that serve as a major source of 
malaria treatment. For-profit outlets, especially in rural 
areas, rarely stock Coartem because clients cannot 
afford it. Furthermore, whereas clinicians have been 
trained about the importance of prescribing Coartem 
because of its efficacy, and they do so; they are aware, 
since clients discuss it with them, that they will buy the 
cheaper antimalarial drugs instead, including 
chloroquine, which is readily available in drug shops 
and grocery shops where medicines are sold. 
The aim to equip all health centres with sufficiently 
trained laboratory personnel, equipment, and supplies 
has also met with many challenges including limited 
staff to confirm tests in the laboratory and 
insufficient/absent supervision and quality control of 
laboratory services. For example, while the proportion 
of health facilities with functional microscopy services 
has increased over the years, still only eight per cent of 
all cases reported in the health management system in 
2004 were laboratory confirmed, due to limited staff in 
health centres. In particular, regular supervision and 
quality control of laboratory services in the public as 
well as in the private sector are still insufficient or 
absent.In the MOH/MCSP [30] it was noted that: 
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Experience also showed that the original plans of 
carrying out net[mosquito] treatment twice a year was 
not achievable with the existing human and financial 
resources and that a campaign once a year is more 
realistic. Furthermore, large scale application of indoor 
residual spraying in at least 2 of the epidemic prone 
districts was envisaged for 2004 funded through the 
GFATM grant but did not happen due to the delays in 
procurement. 
Generally speaking, Uganda’s national malaria 
control programmers have emphasised curative 
measures. In part, this is because over the last decade 
Uganda has been overwhelmed with policy changes 
and research to prove the efficacy of new antimalarials. 
Each research has led to a recommendation of drugs 
other than chloroquine, quinine, and a combination of 
Fansidar and chloroquine. The most controversial 
policy recommendation was the use of Coartem as the 
first-line drug in such a resource-poor setting, though 
this was done with some recognition that high risk 
groups for malaria, including pregnant women and 
children under five years, would continue to be 
recommended affordable and available regimens of 
Fansidar [43]. 
Furthermore, the innovative solutions sought by the 
Bill and Melinda Gates Foundation are a matter of 
transfer: technologies invented in one place are 
retooled and relocated to improve life elsewhere. 
Indeed, for a while the Uganda Malaria Control 
Programme was funded by the Bill and Melinda Gates 
Foundation, but the foundation lost interest when it 
moved from trialling to sustaining the project.This 
abandonment reflects a tension between the innovative 
possibilities of (short-term) aggressive and targeted 
transnational funding and the (rather long-term) 
ecological and socio-political dimensions of disease 
[44]. 
COPING WITH CHALLENGES THROUGH 
RECOMMENDING HOME BASED THERAPY 
In order to complement the (occasionally) available 
free malaria treatment through public health facilities 
and bring it closer to home, a relatively affordable 
programme of home-based management of malaria 
fever for high-risk groups, including children under-five 
years of age, was introduced in ten districts in 2002. 
The drug was initially distributed directly to districts by 
the national Malaria Control Programme, but delivery 
was later integrated into the existing essential 
medicines supply system. Caretakers of children with 
fever access the treatment through volunteers called 
community medicine distributors, of which two are 
selected and trained per village. These community 
medicine distributors report to and receive supplies 
from the nearest health facility, which is also 
responsible for the supervision. Between 2003 and 
early 2005, this programme had gradually been rolled 
out countrywide, including amongst the most 
vulnerable populations and contexts, such as people 
living with HIV/AIDS and those in post-conflict settings. 
People affected by war were regarded as a more 
vulnerable group, because their poor socio-economic 
condition and the fact that they live in camps, coupled 
with a high prevalence of malaria, leads to the deaths 
of a large number of children [30]. 
Regarding home-based management of fever using 
Artemisinin-based Combination Therapy, there is a 
particular challenge in introducing the new drug 
(Coartem), since it involves regulatory issues including 
drug handling and safety, appropriateness, and the 
feasibility of restricting treatment to parasite-positive 
cases by introducing rapid diagnostic tests [30, 45].  
This paper’s main argument is that although 
Uganda’s involvement in global health agenda offers 
both opportunities and challenges in malaria control, 
often, without the resources for the poorest of the 
population to take advantage of the recommendations 
of the global health policies, the policies face socio- 
economic and political obstacles in implementation. 
This will necessarily continue to be the case until there 
are significant budgetary commitments to support these 
health policies (for a similar case of limited supplies of 
antiretroviral drugs in the context of global health 
programs on AIDS treatment in Uganda [46]. 
The Ministry of Health has progressed from 
exclusively preventive approaches, to prevention and 
prophylaxis in malaria control, to a policy focus on 
therapeutic approaches involving a recommendation of 
a relatively expensive regimen of Coartem as a first line 
drug. I have no doubt that Coartem is efficacious for 
uncomplicated episodes of malaria; however, the 
population most at risk does not use it because of its 
high price. Furthermore, its launch as the first-line 
treatment choice must also be considered in the 
context of global pharmaceutical market interests. 
Finally, Uganda’s dependency on global funds has 
served to both distract it from implementing more 
sustainable and effective approaches to malaria 
control, and to a dopt more expensive technology-
based approaches which it cannot sustain without 
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philanthropic financing. 
CONCLUSION 
In sum, because of socio-economic inequality and 
widespread poverty, most of the malaria control 
strategies in Uganda have met with challenges, and 
some control measures were difficult to implement both 
for the Ministry of Health and people in low income 
settings. Whereas adopting the global Roll Back 
Malaria agenda must be interpreted in view of existing 
power relations and the need to promote a unified 
health agenda, as proposed by the WHO, these 
programmes and policies are difficult to implement in 
resource poor settings such as Uganda. Uganda has 
also embedded its Malaria Control Programme in a 
broader five year Health Sector Strategic Plan, which is 
part of the Poverty Eradication Action Plan, where 
malaria features as a high priority health and poverty 
issue [30]. As a consequence, there is a lack in 
Uganda of mechanisms and budgets to follow through 
on global health policies to the implementation level, 
with no commitment to promote health for all. Malaria 
control is a case in point.  
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